(P-2179) Nirsevimab in Patient Samples Does Not Interfere with Respiratory Syncytial Virus (RSV) Detection by Commercially Available Rapid Antigen Tests

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Sarah R. Sincero, BSc (she/her/hers)

Scientist
AstraZeneca
Gaithersburg, Maryland, United States

Katie Streicher, PhD (she/her/hers)

Head of Translational Medicine, Vaccines and Immune Therapies
AstraZeneca
Gaithersburg, Maryland, United States
EK

Elizabeth J Kelly, PhD

AstraZeneca
Gaithersburg, Maryland, United States
Kevin M. Tuffy, MS

Senior Scientist
AstraZeneca
Gaithersburg, Maryland, United States
Deidre Wilkins, BSC (she/her/hers)

Director
Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca
Gaithersburg, MD, United States